Amarantus BioScience
(OTC) AMBS
Amarantus BioScience Financials at a Glance
Market Cap
$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$96.61K
Net Income (TTM)
-$1.75M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
45.96 (High)
Dividend
$0.00
Beta (Volatility)
45.96 (High)
Price
$0.00
Volume
134
Open
$0.00
Price
$0.00
Volume
134
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.25
Estimated Earnings Date
Nov 25, 2024
Dividend
$0.00
Beta (Volatility)
45.96 (High)
Price
$0.00
Volume
134
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.25
Estimated Earnings Date
Nov 25, 2024
AMBS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amarantus BioScience
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Gerald E. Commissiong
Website
www.amarantus.comHeadquarters
New York City, NY 10005, US
AMBS Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-281.13%
Net Income Margin
-4995.23%
Return on Equity
21.36%
Return on Capital
N/A
Return on Assets
-46.65%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
630.41M
Volume
134
Avg. Volume
241.18K
Financials (TTM)
Gross Profit
$96.61K
Operating Income
-$271.10K
EBITDA
-$1.59M
Operating Cash Flow
-$1.49M
Capital Expenditure
$0.00
Free Cash Flow
-$1.49M
Cash & ST Invst.
$0.00
Total Debt
$19.12M
Amarantus BioScience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.28K
N/A
Gross Profit
$1.28K
N/A
Gross Margin
100.00%
N/A
Market Cap
$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$50.00
N/A
Employees
12
N/A
Net Income
-$52.03K
+98.3%
EBITDA
-$60.00K
+98.0%
Quarterly Fundamentals
Total Cash
$0.00
-100.0%
Total Debt
$19.12M
-0.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$19.12M
-0.4%
Return on Assets
-46.65%
N/A
Return on Invested Capital
1.09%
N/A
Free Cash Flow
$7.97K
+100.3%
Operating Cash Flow
$7.97K
+100.3%